Edition:
India

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

529.75INR
2:02pm IST
Change (% chg)

Rs10.60 (+2.04%)
Prev Close
Rs519.15
Open
Rs521.70
Day's High
Rs534.00
Day's Low
Rs521.10
Volume
2,581,558
Avg. Vol
2,765,261
52-wk High
Rs678.45
52-wk Low
Rs507.20

Chart for

About

Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered... (more)

Overall

Beta: 0.47
Market Cap(Mil.): Rs471,067.19
Shares Outstanding(Mil.): 804.69
Dividend: 2.00
Yield (%): 0.34

Financials

  CIPL.NS Industry Sector
P/E (TTM): 43.76 30.86 33.64
EPS (TTM): 13.38 -- --
ROI: -- 14.72 14.22
ROE: -- 16.27 15.99

BUZZ-India's Cipla hits near 5-month low on Q2 profit miss

** Shares of Cipla Ltd fall as much as 7.73 pct to 560.2 rupees, lowest since June 12

05 Nov 2018

Cipla warns of headwinds in second half after second-quarter profit miss

Cipla Ltd, India's second-largest drugmaker by market capitalisation, warned on Monday of "multiple headwinds" in the second half of the financial year after its quarterly profit fell short of analysts' estimates.

05 Nov 2018

UPDATE 1-India's Cipla warns of headwinds in second half after Q2 profit miss

Nov 5 Cipla Ltd, India's second-largest drugmaker by market capitalisation, warned on Monday of "multiple headwinds" in the second half of the financial year after its quarterly profit fell short of analysts' estimates.

05 Nov 2018

India's Cipla Q2 profit dips nearly 11 pct, misses estimate

Nov 5 Drugmaker Cipla Ltd posted a nearly 11 percent fall in second-quarter profit on Monday, much lower than analyst expectations.

05 Nov 2018

Sun Pharma first-quarter profit beats estimates as U.S. sales climb

India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates, helped by stronger sales in the United States.

14 Aug 2018

UPDATE 1-India's Sun Pharma Q1 profit beats estimates as U.S. sales climb

* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)

14 Aug 2018

BUZZ-India's Cipla hits near 9-mth high on Q1 profit beat

** India's third-largest drugmaker by market capitalisation Cipla Ltd's shares rise as much as 4.7 pct to 662.5 rupees, its highest since Nov 2017

09 Aug 2018

Cipla first-quarter profit trumps estimates on strong domestic growth

Indian drugmaker Cipla Ltd posted quarterly profit well above analysts' expectations, helped by strong growth in the domestic market.

08 Aug 2018

UPDATE 1-India's Cipla Q1 profit trumps estimates on strong domestic growth

* India revenue up 22 pct (Adds detail, share movement, appointment of global COO)

08 Aug 2018

India's Cipla Q1 profit trumps estimates

Aug 8 Cipla Ltd, India's third-largest drugmaker by market capitalisation, posted on Wednesday a more than 10 percent rise in its first-quarter profit, well above analysts' expectations.

08 Aug 2018

Earnings vs. Estimates